This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Microbix Biosystems Inc.
Has updated the investor presentation on its corporate website in response to comments of staff of the Ontario Securities Commission in relation to its usage of earnings before interest, taxes, depreciation, and amortization (EBITDA), a measure of financial results not formally-defined by International Financial Reporting Standards. Microbix Biosystems Inc. shares T.MBX are trading unchanged at $0.24.
